1 Dec 2023 07:00
RNS Number : 2865V
Cambridge Cognition Holdings PLC
01 December 2023
1 December 2023
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Total Voting Rights
Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, announces that pursuant to its block admission facility, details of which were announced on 21 March 2023, it has recently issued 25,184 new ordinary shares in the Company in satisfaction of the exercise of employee share options. Accordingly, as at 30 November 2023 the Company has 34,960,109 ordinary shares in issue.
There are no shares held in treasury therefore the total number of voting rights in the Company is 34,960,109. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in Cambridge Cognition under the FCA's Disclosure and Transparency Rules.
Enquiries:
Cambridge Cognition Holdings Plc Matthew Stork, Chief Executive Officer Stephen Symonds, Chief Financial Officer | Tel: 012 2381 0700 press@camcog.com | Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Freddy Crossley / Emma Earl Rupert Dearden | Tel: 020 7886 2968 (Corporate Finance) (Corporate Broking) | Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant | Tel: 020 3903 7715 | IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Graham Herring / Zach Cohen | Tel: 020 3934 6630 |
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRWPGMUGUPWGMU